1. Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure‐response analysis. Issue 4 (2nd August 2019) Authors: Agarwal, Suresh; Gopalakrishnan, Sathej; Mensing, Sven; Potluri, Jalaja; Hayslip, John; Kirschbrown, Whitney; Friedel, Anna; Menon, Rajeev; Salem, Ahmed Hamed Journal: Hematological oncology Issue: Volume 37:Issue 4(2019) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study. Issue 4 (21st March 2021) Authors: de Vos, Sven; Leonard, John P.; Friedberg, Jonathan W.; Zain, Jasmine; Dunleavy, Kieron; Humerickhouse, Rod; Hayslip, John; Pesko, John; Wilson, Wyndham H. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 810 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy. Issue 2 (9th February 2022) Authors: Brackman, Deanna; Eckert, Doerthe; Menon, Rajeev; Salem, Ahmed Hamed; Potluri, Jalaja; Smith, B. Douglas; Wei, Andrew H.; Hayslip, John; Miles, Dale; Mensing, Sven; Gopalakrishnan, Sathej; Zha, Jiuhong Journal: Hematological oncology Issue: Volume 40:Issue 2(2022) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. Issue 4 (April 2018) Authors: Brown, Jennifer R; Hamadani, Mehdi; Hayslip, John; Janssens, Ann; Wagner-Johnston, Nina; Ottmann, Oliver; Arnason, Jon; Tilly, Hervé; Millenson, Michael; Offner, Fritz; Gabrail, Nashat Y; Ganguly, Siddhartha; Ailawadh, Sikander; Kasar, Siddha; Kater, Arnon P; Doorduijn, Jeanette K; Gao, Lei; Lage... Journal: Lancet Issue: Volume 5:Issue 4(2018) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. Issue 4 (April 2018) Authors: Brown, Jennifer R; Hamadani, Mehdi; Hayslip, John; Janssens, Ann; Wagner-Johnston, Nina; Ottmann, Oliver; Arnason, Jon; Tilly, Hervé; Millenson, Michael; Offner, Fritz; Gabrail, Nashat Y; Ganguly, Siddhartha; Ailawadhi, Sikander; Kasar, Siddha; Kater, Arnon P; Doorduijn, Jeanette K; Gao, Lei; Lag... Journal: Lancet Issue: Volume 5:Issue 4(2018) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗